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 What is Research? 
 
 What is Human Subjects Research? 
 
 Brief Historical Perspective 
 
 The elements of the Belmont Report and what that 
means for individuals participating in research? 
 
 What is the Institutional Review Board (IRB)? 
What is Research? 
 A systematic investigation including research 
development, testing and evaluation, designed to develop 
or contribute to generalizable knowledge.  
 
 Generalizable:  If I follow your procedures, I can expect to see 
similar results. 
 
 There are various forms of research: bench or pre-clinical, 
animal studies and human studies. 
 
What is Human Subjects Research? 
 Research that is conducted with human beings or their private, 
identifiable information. 
 
 A living individual about whom an investigator (whether professional or 
student) conducting research obtains: (1) data through intervention or 
interaction with the individual; or (2) identifiable private information. 




Intervention includes both physical procedures by which data are gathered 
(for example, venipuncture) and manipulation of the participant or the 
participant’s environment that are performed for research purposes. 
 
Interaction includes communication or interpersonal contact between 
investigator and participant. 
 
Private information includes information about behavior that occurs in a 
context in which an individual can reasonably expect that no observation 
or recording is taking place, and information which has been provided for 
specific purposes by an individual and which the individual can reasonably 
expect will not be made public (for example, a medical record). Private 
information must be individually identifiable (i.e., the identity of the 
participant is or may readily be ascertained by the investigator or 
associated with the information) in order for obtaining the information to 
constitute research involving human participants. 
 45 CFR 46.102 (f) 
 
Brief Historical Perspective 
 Experimentation has always taken place. 
 
 The Hippocratic Oath originally written by Hippocrates 
in late 5th century first stated: 
 “I will prescribe regimens for the good of my patients 
according to my ability and my judgment and never do harm to 
anyone.” 
 
 However, in the course of experimentation people were 
harmed and sometimes killed. 
 
 
Historical Studies – Nazi Germany 
1939-1944 
 To test the effects of extremely high altitudes internees 
were put in vacuum chambers that duplicated low air 
pressure and lack of oxygen at altitudes as high as 65,000 
ft.  
 To test hypothermia, internees were: immersed in tubs of 
ice water; or fed salt water for days; or penned outside 
without clothing or shelter in sub-freezing temperatures 
for 12-14 hours and some were sprayed with cold water. 
 
 Battlefield medicine including treatment of wounds, burns, 
traumatic amputations, chemical and biological agent 
exposure that was first inflicted on the victim. 
Historical Studies - USA 
 The Public Health Service Syphilis Study in Tuskegee, AL, 
1932-72 
 
 Willowbrook Experiment, 1956-72,  Willowbrook State 
School in New York for mentally disabled children. 
Children were infected with a mild form of hepatitis. 
 
 Milgram Study, 1963, was designed to study the role of 
obedience to authority; why ordinary people behave in 
ways that seem inhumane outside a certain context. 
 
Studies talked about in 2010   
 HeLa Cells, 1951. Henrietta Lacks was diagnosed with 
cervical cancer. Her physician removed some of the 
cancerous cells and developed the first “immortal” human 
cells grown in culture. 
 
 Havasupai Tribe, 1992.  Blood samples were taken to 
study occurrence of diabetes amongst tribe members but 
were used for other studies as well. 
 
 US Public Health Service in Guatemala, 1946.  Male 
prisoners in Guatemala were infected with syphilis using 
infected female prostitutes. 
 
Establishment of IRBs  
 Federal regulations were codified in 1974 that established 
institutional review boards. 
 
 IRBs are charged with reviewing human subjects research 
to ensure that it meets federal, state, and ethical codes. 
 
 WU IRBs Mission: To protect the rights and welfare of 
Human Subjects 
 IRBs follow the guiding principles in Belmont Report 
 
 
The Belmont Report 
 
 Respect for Persons, that includes concepts of Autonomy and 
Informed Consent as well as extra Protections for vulnerable 
populations 
 
 Beneficence, that involves Risk vs. Benefit analysis 
 
 Justice, meaning Equitable Subject Selection for a given study. 
Respect for Persons 
 All individuals are autonomous individuals and can make 
decisions for themselves when given appropriate 
information. 
 Consent, whether written, verbal or implied 
 You must consent participants in the manner approved for the 
protocol 
 All elements of consent should be appropriate whenever 
appropriate 
Elements of Consent 
 Purpose of the study 
 All steps of participation 
 Any costs that will pass along to the participant 
 Any payments the participant will receive 
 Risks of any and all drugs, devices, treatments and/or 
procedures 
 Benefits to the participant and/or society 
 Maintenance of confidentiality 
Elements of Consent 
 Contacts in case of any emergency 
 The right to withdraw at any time. 
 If there are consequences to withdraw as in some 
investigational drug and device studies, how withdrawal will 
occur safely and if the participant still needs to come back for 
follow-up safety visits. 
 
 For studies deemed greater than minimal risk, who will 
pay in case a research related injury occurs. 
 Alternatives to the research, if any 
Other Elements of Consent that may need to 
be included depend on study 
 The number of individuals that will be enrolled study-wide if 
the study is being conducted at more than one site. 
 
 Conditions under which a participant’s time in a research 
study will be terminated by the PI. 
 
 That the social security number will be obtained. This is 
needed any time a payment or gift is given per IRS 
regulations. 
 
 Any new significant findings during the course of the study 





 HIPAA authorization is different from consent. 
 It is built in to the WU consent templates for studies 
where this is needed. 
 
 It gives permission to access, use, create and share 
protected health information outside of treatment, 
payment, operations functions as in a research study. 
 If PHI is being used, HIPAA authorization language should 
be in the consent document. 
Research Consent Process 
 Is longer than a clinical consent process. 
 
 The document is longer and contains more detailed 
information. 
 
 Process begins at recruitment when you first begin to tell 
the potential participant about the study. 
 
 The participant should be given adequate time to decide 
whether or not to enroll.  
 This varies by study 
Research Consent Process 
 Ideally, the participant is given the consent document to 
read then a qualified study team member discusses the 
study and any questions with the potential participant 
before he/she agrees to enroll. 
 You are a member of the study team and should be familiar with 
the study procedures as well as what you are expected to do 
for this study 
 Consent does not end with the initial enrollment.  
Subsequent conversations/contacts are not uncommon and 
help keep the participant informed all along.  
 This is considered re-consent as you verify continued 
enrollment with each conversation/contact and note this in your 
research record. 





 Additional Protections for vulnerable populations 
Privacy and Confidentiality 
Definitions 
• Privacy: The freedom of the individual to pick and 
choose for him/herself the time and circumstances 
under which, and to the extent to which his/her 
attitudes, beliefs, behavior and opinions are to be 
shared with or withheld from others. (Levine, p 163) 
 
• Confidentiality: Mode of management of private 
information. (Levine, p. 163) 
Privacy or Confidentiality? 
1. Consenting a participant in a private room 
 
2. Keeping data behind two locked doors 
 
3. Devising a recruitment process whereby everyone in the 
room returns a piece of paper whether or not he/she 
wants further information about the study  
 
4. Limiting access to identifiable information 
 
5. Using fire walls to secure data 
 
Confidentiality Measures 
Type of Confidentiality Data Protection Consent Measures 
Full identifiers  Research participants fully 
identifiable 
Consent/authorization 
obtained to collect, use, 
share 
Coded or De-identification 
of  Data or Samples 
Those outside the research 
team cannot identify 
participants 
Consent/authorization to 
collect and use. Normally 
shared de-identified or 
coded. 
Data or samples de-
identified prior to study 
initiation 
Study team does not have 





Anonymous samples No individually identifiable 




Additional Protections for 
Vulnerable Populations 
 Name a vulnerable population. 




 Employees – heightened confidentiality so employment is not 
affected 
 Terminally ill – use of a research advocate to avoid undue 
influence and increase understanding 
 Socioeconomically disadvantaged – payment not so great that 
will entice one to enter a study that he/she would not normally 
consider 
Beneficence 
 Identification of harms 
 Physical  - drug toxicities, exposure to radiation, research 
injuries 
 Psychological – emotional distress, anxiety in making choice 
 Social – one’s reputation, social standing, retaliation 
 Legal – risk of criminal or civil liability 
 Economic – impact on employment, insurance, research costs 
 
 Minimizing those harms 
 Physical – use of standard care procedures 
 Psychological – time to talk to family 
 Economic – letting participant know if there will be any costs 
 
 
Conflicts of Interest 
 Can impose more harms or prevent harms to be 
minimized, potentially 
 E.g. The PI is the person who developed the device. He/she 
wants the trial to go well so he/she overlooks some negative 
results or effects whether intentionally or unintentionally.  The 
participant may/may not be harmed. But, this will affect data 
validity. 
 So, it’s important to know if there is any conflict of interest for 
any research team member or anyone in his/her immediate 
family. 
Beneficence 
 Identification of possible benefits 
 
 Being able to put one participant through the possible 
risks for the potential benefits. 
 Possible risks: these are known risks that are in current 
literature, seen clinically, in the investigator’s brochure or 
device pamphlet, seen in previous studies using the same 
drug/device, etc. 
 
Justice: Equitable Subject Selection 
 Given the study and what it is trying to accomplish, 
are appropriate populations targeted for inclusion and 
are appropriate populations excluded. 
 We don’t want to take advantage of populations or exclude 
populations inappropriately. 
 
IRB review is required 
 Before human subjects research is initiated. 
 
 Anytime there is a change to the research 
 
 When an event occurs that would create an increased 
risk to research participants. 
 
 At the time of renewal. 
 Most studies are renewed every 12 months. 
 
 
IRB at WU  
 Consists of 12 committees: 
 10 review new studies and renewals that are either deemed “greater than 
minimal risk” or cannot be reviewed using expedited review procedures. 
 
 1 handles all studies and events considered “minimal risk” and those 
allowable under expedited review procedures (1 reviewer). 
 
 1 handles compliance issues 
 
 Total membership is around 250 individuals comprised of 
physician scientists, other scientists, and community 
representatives. 
Types of Research Seen by the WU IRB 
 Include: 
 Social, Behavioral, and Educational Studies 
Questionnaires, observations, interviews, studies regarding human 
behavior 
 
 Biomedical Studies 
Medical interventions and therapies, use of investigational drug 
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When to call the IRB 
 Anytime you have a question or concern regarding the 
study. 
